Inhibrx Biosciences (INBX) Other Working Capital Changes (2023 - 2025)
Inhibrx Biosciences' (INBX) quarterly Other Working Capital Changes came in at -$535000.0 in Q4 2025, down 664.29% year-on-year from $94810.1 in Q4 2024, and down 2.49% on a QoQ basis from -$522000.0 in Q3 2025.
Inhibrx Biosciences (INBX) Other Working Capital Changes (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Other Working Capital Changes data on file, last reported at -$535000.0 in Q4 2025.
- On a quarterly basis, Other Working Capital Changes fell 664.29% year-over-year to -$535000.0 in Q4 2025; TTM through Dec 2025 was -$1.6 million, a 13.28% decrease from a year earlier, with the FY2025 full-year figure at -$1.6 million, down 13.28% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$535000.0, down from -$522000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for INBX reached as high as $15.1 million in Q3 2023 and fell as low as -$9.0 million in Q4 2023.
- Historically, Other Working Capital Changes has averaged $177200.0 across 3 years, with a median of -$322500.0 in 2025.
- Across the five-year window, Other Working Capital Changes soared 85.54% in 2024 and slumped 664.29% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$484000.0 in 2023, then surged by 85.54% to -$70000.0 in 2024, then slumped by 664.29% to -$535000.0 in 2025.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$535000.0 in Q4 2025, -$522000.0 in Q3 2025, and -$367000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Inhibrx Biosciences | 1.32 Bn | 1.32 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -535,000.00 |
| Dec 31, 2025 | -535,000.00 |
| Dec 31, 2025 | -535,000.00 |
| Sep 30, 2025 | -522,000.00 |
| Sep 30, 2025 | -522,000.00 |
| Sep 30, 2025 | -522,000.00 |
| Jun 30, 2025 | -367,000.00 |
| Jun 30, 2025 | -367,000.00 |
| Jun 30, 2025 | -367,000.00 |
| Mar 31, 2025 | -171,000.00 |
| Mar 31, 2025 | -171,000.00 |
| Mar 31, 2025 | -171,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Sep 30, 2024 | -336,000.00 |
| Sep 30, 2024 | -336,000.00 |
| Sep 30, 2024 | -336,000.00 |
| Jun 30, 2024 | -507,000.00 |
| Jun 30, 2024 | -507,000.00 |